Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 62.29 | N/A |
| PEG Ratio (TTM) | 0.41 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 15.23 | N/A |
| P/FCF Ratio (TTM) | -10,777.62 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.59% | N/A |
| ROE (TTM) | 4.75% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -11,114,337.08% | N/A | N/A |
| Revenue | 86,074,977.72% | N/A | N/A |
| Net Income | -16,813,908.41% | N/A | N/A |
| Cash Flow | 30.22% | N/A | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 38.28 | N/A |
| Quick Ratio (TTM) | 38.28 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |